Huntington Bancshares
HBAN
$17.03
-0.18%
Huntington Bancshares Inc. is a regional U.S. bank holding company headquartered in Columbus, Ohio, offering a comprehensive suite of consumer and commercial banking services, including deposits, lending, payments, treasury management, and capital markets solutions, with over $285 billion in assets. As one of the largest regional banks in the Midwest, Huntington differentiates itself through its 'Fair Play' philosophy and a strong focus on relationship banking, serving retail, small business, and middle-market clients across a multi-state footprint. The current investor narrative centers on Huntington's ability to sustain revenue growth amid a shifting interest rate environment, with recent quarterly results showing a 26.3% year-over-year revenue surge, while the stock has underperformed the broader market over the past year, prompting debate about its valuation and growth sustainability. Management's strategic investments in technology and fee-based services, alongside a solid capital position, are key focal points as analysts assess the bank's earnings power and potential for margin expansion.…
HBAN
Huntington Bancshares
$17.03
Investment Opinion: Should I buy HBAN Today?
Based on the analysis, HBAN is rated a Buy. The consensus rating is Buy with an average target price of $20.30, implying 19.2% upside. The thesis is that HBAN's accelerating revenue growth and attractive valuation (forward PE of 9.07x) are not fully reflected in the stock price, offering a favorable risk/reward.
Sign up to view all
HBAN 12-Month Price Forecast
The AI model assesses HBAN as bullish with medium confidence. The strong revenue acceleration and low valuation suggest upside potential, but the recent margin compression and underperformance relative to the market warrant caution. The model would upgrade to high confidence if net margins stabilize and revenue growth continues above 20%. Conversely, a downgrade to neutral would occur if revenue growth decelerates below 10% or if the Fed signals aggressive rate cuts.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Huntington Bancshares's 12-month outlook, with a consensus price target around $20.30 and implied upside of +19.2% versus the current price.
Average Target
$20.30
0 analysts
Implied Upside
+19.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$18 - $23
Analyst target range
Analyst coverage is robust with 19 analysts providing ratings, and the consensus recommendation is 'Buy' with a mean rating of 1.8 (where 1 is Strong Buy and 5 is Sell). The average target price is $20.30, implying an upside of 19.2% from the current price of $17.03. The distribution shows a bullish tilt, with recent actions from UBS (Buy), JP Morgan (Overweight), and Morgan Stanley (Overweight) reaffirming positive sentiment, though Jefferies downgraded from Buy to Hold in July 2026, indicating some caution. The target price range spans from $18.00 to $23.00, with the low target suggesting a modest 5.7% upside, likely pricing in potential margin compression or economic downturn, while the high target implies a 35.1% upside, reflecting expectations of continued revenue acceleration and improved efficiency. The relatively wide spread of $5.00 between low and high targets indicates moderate uncertainty about the bank's future performance, but the overall consensus leans strongly bullish, supported by the bank's solid fundamentals and attractive valuation.
Bulls vs Bears: HBAN Investment Factors
Huntington Bancshares presents a compelling value opportunity with accelerating revenue growth, a low valuation, and strong analyst support. However, the stock's significant underperformance relative to the market and recent margin compression are concerning. The bull case is currently stronger, driven by the 26.3% revenue surge and a forward PE of 9.07x, but the key tension lies in whether the bank can sustain its growth and margin expansion in a potentially lower-rate environment. If net interest margins hold and revenue growth continues, the stock could re-rate higher; if not, the discount to peers may persist or widen.
Bullish
- Revenue Growth Accelerating Sharply: Q1 2026 revenue surged 26.3% YoY to $3.768B, up from 8.7% growth in Q4 2025 and 5.8% in Q3 2025. This acceleration is driven by strong net interest income and fee-based revenue, indicating robust business momentum.
- Attractive Valuation with PEG Below 1: Trailing PE is 12.3x, forward PE is 9.07x, and PEG is 0.90, suggesting the stock is undervalued relative to its expected earnings growth of ~35.6%. This is a compelling value proposition for a regional bank.
- Strong Analyst Consensus and Upside: 19 analysts rate HBAN a Buy with a mean rating of 1.8. The average target price is $20.30, implying 19.2% upside from the current $17.03, with a high target of $23.00 offering 35.1% upside.
- Solid Capital Position and Dividend: Debt-to-equity is a manageable 0.76, and the bank generated $2.206B in TTM free cash flow. The dividend yield is 3.96% with a payout ratio of 45.95%, providing a stable income stream.
Bearish
- Significant Underperformance vs. Market: HBAN is down 4.75% over the past year, while the S&P 500 gained 18.65%, resulting in a relative strength of -23.40%. This persistent underperformance may indicate structural issues or investor skepticism.
- Margin Compression and Rising Costs: Net margin declined from 19.49% in Q3 2025 to 13.88% in Q1 2026, and operating expenses rose. This sequential deterioration suggests cost pressures that could erode future profitability.
- Sensitivity to Interest Rate Environment: As a regional bank, HBAN's net interest income is highly sensitive to Federal Reserve policy. If the Fed cuts rates, net interest margins could compress, impacting earnings. The recent revenue surge may partly reflect a favorable rate environment that could reverse.
- Valuation Discount May Signal Risk: HBAN trades at a 18% discount to the industry average PE of 15.0x. While this could be a value opportunity, it may also reflect concerns about asset quality, regional economic exposure, or future growth sustainability.
HBAN Technical Analysis
Huntington Bancshares has been in a broad recovery phase over the past year, with the stock currently trading at $17.03, down 4.75% from a year ago but up 4.41% over the past six months. The price sits at 72.4% of its 52-week range (between the low of $14.89 and high of $19.46), indicating a mid-range position that suggests neither overbought nor deeply oversold conditions. The stock's beta of 0.941 implies slightly lower volatility than the broader market, which may appeal to risk-averse investors, but the 1-year relative strength of -23.40% versus the S&P 500 highlights significant underperformance that warrants caution.
Beta
0.94
0.94x market volatility
Max Drawdown
-22.1%
Largest decline past year
52-Week Range
$15-$19
Price range past year
Annual Return
-4.8%
Cumulative gain past year
| Period | HBAN Return | S&P 500 |
|---|---|---|
| 1m | -3.2% | -0.4% |
| 3m | +3.1% | +4.5% |
| 6m | +4.4% | +13.9% |
| 1y | -4.8% | +19.0% |
| ytd | -2.6% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HBAN Fundamental Analysis
Huntington's revenue trajectory has been robust, with the most recent quarter (Q1 2026) reporting revenue of $3.768 billion, a 26.32% year-over-year increase, accelerating from the 8.7% growth seen in Q4 2025 and 5.8% in Q3 2025. This acceleration is driven by strong net interest income and fee-based revenue, with segments like cards and payment processing contributing $177 million and trust services adding $120 million. The company's profitability is solid, with net income of $523 million in Q1 2026, translating to a net margin of 13.88%, up from 15.98% in Q4 2025 but down from 19.49% in Q3 2025, reflecting some margin compression due to higher operating expenses. Gross margin stands at 64.09%, and operating margin is 17.01%, indicating healthy core banking operations, though the sequential decline in net margin suggests cost pressures that need monitoring. The balance sheet remains well-capitalized with a debt-to-equity ratio of 0.76, and the company generated $400 million in free cash flow in Q1 2026, with $2.206 billion in trailing twelve-month free cash flow, supporting its dividend payout ratio of 45.95% and a dividend yield of 3.96%. Return on equity is 9.08%, and return on assets is 0.98%, both within typical ranges for regional banks, indicating efficient use of capital.
Quarterly Revenue
$3.8B
2026-03
Revenue YoY Growth
+26.3%
YoY Comparison
Gross Margin
64.1%
Latest Quarter
Free Cash Flow
$2.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HBAN Overvalued?
Given Huntington's positive net income, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 12.30x, while the forward PE is 9.07x, implying the market expects earnings growth of approximately 35.6% over the next year, which aligns with analyst EPS estimates of $1.73 for the upcoming fiscal year. The stock's PEG ratio of 0.90 suggests it is undervalued relative to its growth rate, and the price-to-book ratio of 1.05x is near its historical average, indicating a reasonable valuation for a regional bank. Compared to the industry average PE of 15.0x (based on historical data), Huntington trades at an 18% discount, which may reflect concerns about asset quality or regional economic exposure, but the discount appears unwarranted given its strong revenue growth and profitability metrics. Historically, Huntington's PE has ranged from 7.0x to 21.2x over the past five years, and the current trailing PE of 12.30x sits near the lower end of that band, suggesting the stock is trading at a discount to its own historical norm, potentially offering a value opportunity if the bank can sustain its growth trajectory.
PE
12.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, HBAN's revenue growth is impressive but may be partly driven by a favorable interest rate environment that could reverse. The net margin fell from 19.49% in Q3 2025 to 13.88% in Q1 2026, indicating rising costs. Debt-to-equity is 0.76, which is manageable, but the current ratio of 0.19 is low, suggesting potential liquidity concerns. The bank's reliance on net interest income makes it vulnerable to rate cuts, and any economic downturn could increase loan loss provisions, pressuring earnings.
FAQ
The key risks include: 1) Interest rate risk - if the Fed cuts rates, net interest margins could compress, reducing earnings; 2) Margin compression - net margin fell from 19.49% to 13.88% in recent quarters, indicating rising costs; 3) Economic downturn - a recession could increase loan defaults and credit costs; 4) Underperformance risk - the stock has lagged the market by 23.4% over the past year, and this trend could continue. The most severe risk is a combination of rate cuts and economic weakness, which could drive the stock down to its 52-week low of $14.89.
The 12-month forecast is moderately bullish. The base case (50% probability) sees the stock reaching the average analyst target of $20.30, implying 19.2% upside. The bull case (30% probability) targets $23.00, while the bear case (20% probability) could see the stock fall to $14.89. The most likely scenario is the base case, assuming revenue growth continues at a healthy pace but margins stabilize. Investors should monitor quarterly earnings and Fed policy for signs of which scenario is unfolding.
HBAN is undervalued based on its forward PE of 9.07x, which is 40% below the industry average of 15x. Its PEG ratio of 0.90 indicates the stock is cheap relative to its expected earnings growth. The price-to-book ratio of 1.05x is near its historical average, suggesting fair value on that metric. The market appears to be pricing in concerns about margin compression and regional economic exposure, but the strong revenue growth and profitability metrics suggest the discount is unwarranted. Overall, HBAN offers a value opportunity.
HBAN appears to be a good buy for investors seeking a value opportunity with income. The stock trades at a forward PE of 9.07x, a significant discount to the industry average of 15x, and offers a 3.96% dividend yield. Analyst consensus is Buy with an average target of $20.30, implying 19.2% upside. However, the stock has underperformed the market, and margin compression is a risk. It is a good buy for those with a 12-month horizon who believe the revenue growth is sustainable, but not for those seeking immediate market-beating returns.
HBAN is more suitable for long-term investment, given its stable dividend yield of 3.96% and potential for value appreciation. The stock's beta of 0.941 indicates lower volatility than the market, making it a defensive choice. However, its underperformance and sensitivity to interest rates suggest it may not be ideal for short-term trading. A minimum holding period of 12 months is recommended to allow the revenue growth and valuation re-rating to play out. For income-focused investors, a longer horizon of 3-5 years could provide steady returns from dividends and potential capital gains.